Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 05-2023 | 02-2023 | 11-2022 | 09-2022 | 08-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,958 | 33,571 | 64,474 | 64,474 | 47,556 |
| Marketable Securities | 222,219 | 243,575 | 244,667 | 244,667 | 296,922 |
| TOTAL | $290,014 | $288,329 | $318,449 | $318,449 | $354,871 |
| Non-Current Assets | |||||
| PPE Net | 18,495 | 17,717 | 17,163 | 17,163 | 16,501 |
| Investments And Advances | 27,463 | 48,449 | 63,879 | 63,879 | 69,125 |
| Other Non-Current Assets | 14,652 | 15,659 | 17,268 | 17,268 | 18,841 |
| TOTAL | $60,610 | $81,825 | $98,310 | $98,310 | $104,467 |
| Total Assets | $350,624 | $370,154 | $416,759 | $416,759 | $459,338 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,525 | 5,629 | 5,064 | 5,064 | 6,053 |
| Accrued Expenses | 18,091 | 15,388 | 22,428 | 22,428 | 19,609 |
| TOTAL | $72,262 | $64,878 | $70,655 | $70,655 | $67,500 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 44,063 | 38,305 | 37,633 | 37,633 | 36,342 |
| Other Non-Current Liabilities | 3,758 | 5,106 | 6,434 | 6,434 | 7,745 |
| TOTAL | $18,441 | $31,224 | $42,408 | $42,408 | $49,293 |
| Total Liabilities | $90,703 | $96,102 | $113,063 | $113,063 | $116,793 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,200 | 47,445 | 47,273 | N/A | 47,148 |
| Common Shares | 48 | 47 | 47 | 47 | 47 |
| Retained earnings | -466,262 | -441,985 | -401,252 | -401,252 | -354,535 |
| Other shareholders' equity | -1,903 | -3,247 | -4,319 | -4,319 | -3,742 |
| TOTAL | $259,921 | $274,052 | $303,696 | $303,696 | $342,545 |
| Total Liabilities And Equity | $350,624 | $370,154 | $416,759 | $416,759 | $459,338 |